Skip to main content
. 2020 Apr;8(7):472. doi: 10.21037/atm.2020.03.129

Figure 8.

Figure 8

The survival rates and curve for different groups with Kaplan-Meier and log-rank analysis (P=0.02). group A, SRL-based therapy/SRL+; group B, SRL/RAPA; group C, Thymalfasin/Zadaxin; group D, Huaier extract/PS-T; group E, HCC model; group F, Blank/Control.